Moderna’s Bancel Prepares for Transition Year as COVID Vaccine Sales Wane
(Bloomberg) -- Moderna Inc. is looking for potential approval of two new vaccines this year to help compensate for waning sales of its Covid-19 shot, according to Chief Executive Officer Stephane Bancel.